June 2020 nbcnews; The Food and Drug Administration rescinded the emergency use authorization for hydroxychloroquine to treat hospitalized COVID-19 patients on Monday, saying the drug carries too many risks without any apparent benefit. The authorization was first issued in March, and applied to patients hospitalized with the illness and those in clinical …
Read More »
June 2020 Zeit; According to a publication, hydroxychloroquine should not work in corona patients and have possible serious side effects. There are now doubts about the study. Due to criticism of the methodology and data collection for a study on the use of hydroxychloroquine as a corona drug, the journal The …
Read More »
March 2020 YahooNews; The Food and Drug Administration on Sunday approved the anecdotally promising malaria drug for emergency use to treat hospitalized patients for COVID-19. The U.S. Department of Health and Human Services (HHS) said in a statement it has accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis …
Read More »
Universal Health 2030 Solving Complex Health System Problems